Cytiva enables the development, manufacture and delivery of transformative medicines to patients.In October 2022, Cytiva had announces the acquisition of CEVEC Pharmaceuticals.In July 2021, Cytiva acquired Intermountain Life Sciences.In February 2021, Cytiva acquired Vanrx Pharmasystems Inc.In July 2021, Cytiva and Pall Corporation invested 1.5 billion USD to meet the growing demand for biotechnology solutions; Cytiva是一家细胞和基因疗法CDMO，积极携手学术及转化医学领域研究人员、生物技术开发者和制造商，专注于生物药物、细胞和基因疗法以及以mRNA为代表的一系列创新技术的研究，通过提升药物研发和生物工艺的速度、效率、灵活性和能力，为惠及全球患者开发和生产变革性药物和疗法。